Status:
COMPLETED
Prevention of Adverse Pregnancy Outcome With Vitamin D Supplementation During Pregnancy
Lead Sponsor:
Dow University of Health Sciences
Collaborating Sponsors:
Yale University
Conditions:
Pregnancy
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
We hypothesized that vitamin D supplementation during pregnancy can prevent adverse pregnancy outcome.
Detailed Description
Vitamin D deficiency has been associated with many chronic diseases. These include cardiovascular diseases, diabetes mellitus, multiple sclerosis, breast and prostate cancers. Recently, its role in pr...
Eligibility Criteria
Inclusion
- Pregnant women attending antenatal clinic at ≤ 20 weeks of gestation
- Normoglycemic, normotensive at the time of antenatal booking
Exclusion
- Multiple pregnancy
- H/O hypertensive disorders in previous pregnancy
- Known diabetic or h/o gestational diabetes in previous pregnancy
- H/O endocrine disorders ( thyroid, parathyroid dysfunction)
- Chronic renal diseases
- Tuberculosis
- Breast feeding (current)
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT01418664
Start Date
September 1 2010
End Date
May 1 2012
Last Update
April 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dow University of Health Sciences
Karachi, Sindh, Pakistan, 74200